ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Bobbie3136
|
872 |
227K |
7 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
872
|
227K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Bobbie3136
|
872 |
227K |
12 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
872
|
227K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Bobbie3136
|
872 |
227K |
22 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
872
|
227K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
Bobbie3136
|
24 |
6.5K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
24
|
6.5K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
Bobbie3136
|
24 |
6.5K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
24
|
6.5K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
Bobbie3136
|
24 |
6.5K |
10 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
6.5K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
|
|
Bobbie3136
|
19 |
6.1K |
2 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
19
|
6.1K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
|
|
Bobbie3136
|
19 |
6.1K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
19
|
6.1K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Bobbie3136
|
872 |
227K |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
872
|
227K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Bobbie3136
|
872 |
227K |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
872
|
227K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Bobbie3136
|
12 |
2.9K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
12
|
2.9K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Bobbie3136
|
317 |
84K |
4 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
317
|
84K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Bobbie3136
|
317 |
84K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
317
|
84K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Bobbie3136
|
317 |
84K |
3 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
317
|
84K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAAO holders as at 29 Feb 2024
|
|
Bobbie3136
|
35 |
8.2K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
35
|
8.2K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Bobbie3136
|
1.4K |
370K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1.4K
|
370K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAAO holders as at 29 Feb 2024
|
|
Bobbie3136
|
35 |
8.2K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
35
|
8.2K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA holders as at 29 Feb 2024
|
|
Bobbie3136
|
11 |
3.5K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
11
|
3.5K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAAO holders as at 29 Feb 2024
|
|
Bobbie3136
|
35 |
8.2K |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
35
|
8.2K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Bobbie3136
|
317 |
84K |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
317
|
84K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
Bobbie3136
|
209 |
52K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
52K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
Bobbie3136
|
209 |
52K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
52K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Bobbie3136
|
287 |
80K |
5 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
287
|
80K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Bobbie3136
|
430 |
112K |
3 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
430
|
112K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Balance of PAAOA holders as at 29 December 2023
|
|
Bobbie3136
|
6 |
1.8K |
1 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
6
|
1.8K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results of Annual General Meeting
|
|
Bobbie3136
|
29 |
7.6K |
5 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
29
|
7.6K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 PAA Shareholders as at 31 October 2023
|
|
Bobbie3136
|
8 |
2.1K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
8
|
2.1K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 PAA Shareholders as at 31 October 2023
|
|
Bobbie3136
|
8 |
2.1K |
2 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
8
|
2.1K
|
2
|
|
ASX - By Stock
|
PWN |
Re:
general chat/ thoughts
|
|
Bobbie3136
|
3.2K |
1.0M |
0 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
3.2K
|
1.0M
|
0
|
|
ASX - By Stock
|
PWN |
Re:
general chat/ thoughts
|
|
Bobbie3136
|
3.2K |
1.0M |
1 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
3.2K
|
1.0M
|
1
|
|
ASX - By Stock
|
DVP |
Re:
Ann: Eligible Shareholder Letter
|
|
Bobbie3136
|
5 |
2.7K |
2 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
5
|
2.7K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
Bobbie3136
|
200 |
43K |
3 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
200
|
43K
|
3
|
|
ASX - By Stock
|
PWN |
Re:
Research Report 8 cents to 50 cents a share
|
|
Bobbie3136
|
49 |
21K |
3 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
49
|
21K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR Maintains Exceptional Results in New Patient Cohort
|
|
Bobbie3136
|
35 |
14K |
0 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR Maintains Exceptional Results in New Patient Cohort
|
|
Bobbie3136
|
35 |
14K |
0 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
PWN |
Re:
ChatGPT-4 Answer
|
|
Bobbie3136
|
8 |
3.6K |
0 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
8
|
3.6K
|
0
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Launch of Parkway Investor Hub
|
|
Bobbie3136
|
22 |
12K |
2 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
22
|
12K
|
2
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Bobbie3136
|
52 |
17K |
0 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
52
|
17K
|
0
|
|
ASX - By Stock
|
PWN |
Re:
Meeting with Bahay
|
|
Bobbie3136
|
24 |
10K |
3 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
24
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Settlement of $35M Capital Raising Transaction
|
|
Bobbie3136
|
205 |
67K |
0 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
205
|
67K
|
0
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Notification of cessation of securities - PWN
|
|
Bobbie3136
|
3 |
1.9K |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
3
|
1.9K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
New research report from Evolution Capital
|
|
Bobbie3136
|
38 |
13K |
0 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
38
|
13K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
New research report from Evolution Capital
|
|
Bobbie3136
|
38 |
13K |
0 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
38
|
13K
|
0
|
|
ASX - By Stock
|
PWN |
Re:
general chat/ thoughts
|
|
Bobbie3136
|
3.2K |
1.0M |
0 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
0
|
|
ASX - By Stock
|
VMS |
Re:
Ann: Feasibility Study Manager appointed, and drilling completed
|
|
Bobbie3136
|
88 |
34K |
0 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
88
|
34K
|
0
|
|
ASX - By Stock
|
DVP |
Re:
Ann: Woodlawn Zinc Copper Project Acquisition Presentation
|
|
Bobbie3136
|
79 |
28K |
3 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
79
|
28K
|
3
|
|
ASX - By Stock
|
DVP |
Re:
Ann: Woodlawn Zinc Copper Project Acquisition Presentation
|
|
Bobbie3136
|
79 |
28K |
4 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
79
|
28K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
TCT DurAVR presentation Nov 21
|
|
Bobbie3136
|
29 |
8.1K |
2 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
29
|
8.1K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
TCT DurAVR presentation Nov 21
|
|
Bobbie3136
|
29 |
8.1K |
8 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
29
|
8.1K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Bobbie3136
|
1.4K |
378K |
4 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
1.4K
|
378K
|
4
|
|